Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet

Walgreens Boots Alliance agreed to an $11.45 per share buyout by Sycamore Partners, but shareholders can reject the deal and holdout for a better offer.

5 ETFs Poised to Spring Ahead in the Second Quarter

5 ETFs Poised to Spring Ahead in the Second Quarter

Here are five thematic ETFs that appear to be ideal for the current market conditions; each fund is delivering strong performance with low fees

3 Stocks With Sky-High Buyback Yields Over the Last 12 Months

3 Stocks With Sky-High Buyback Yields Over the Last 12 Months

Check out these three stocks that have bought back shares big-time over the past 12 months, resulting in buyback yields of 10% or more.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Top 3 Utilities Stocks Powering Up as Recession Fears Rise

Three utilities firms may stand out to investors seeking a refuge amid concerns about an impending recession, although each has a different profile.

Hidden Gems: 5 Stocks Under $10 With Massive Growth Potential

Uncover five promising stocks under $10, each poised for gains across diverse sectors for the second quarter of 2025.

Costco Price Plunge Equals Opportunity for Investors

Costco continues to take share from its competitors as it leads the industry in growth. Analysts are lifting their stock price targets, leading to new highs.

3 Stocks Investing $650 Billion in the U.S.—Should You Invest?

See which three large-cap stocks are planning to invest a total of over $650 billion in the United States over the next several years.

inkl

Read news from The Economist, FT, and more,
with one subscription

Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors

Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors

Novo Nordisk slashed prices on its GLP-1 obesity drugs as it launches NovoCare to gain compounded GLP-1 users as the compounding labs face deadlines to cease.

3 Tech Stocks Defying Sector Weakness and Thriving in 2025

3 Tech Stocks Defying Sector Weakness and Thriving in 2025

Check out these three tech stocks that are all up at least 15% this year. They are defying the disappointing performance of the tech sector so far in 2025.

Energy and Basic Materials Sectors Will Dominate in 2025

Energy and Basic Materials Sectors Will Dominate in 2025

Put option buyers might have just bet the wrong way about the energy and basic materials sectors, where investors can profit.

Silver Pushes Past Gold This Year, These Stocks Will Capitalize

Silver Pushes Past Gold This Year, These Stocks Will Capitalize

Three companies focusing primarily on silver mining may appeal to investors looking to capitalize on the metal's strong performance in 2025.

These 3 Q1 Earnings Winners Will Go Higher

These 3 Q1 Earnings Winners Will Go Higher

Despite a lackluster earnings season for many companies, these three firms stood out and exhibited signs of likely future growth as a bonus.

Archer Aviation Stock Climbs as Midnight eVTOL Nears Reality

Archer Aviation Stock Climbs as Midnight eVTOL Nears Reality

Archer Aviation's Midnight aircraft is showing great potential in the eVTOL market, supported by strong financial backing and key strategic partnerships.

3 Defensive Investments for a Market Under Pressure

3 Defensive Investments for a Market Under Pressure

Defensive investments like Gold, Consumer Staples, and Dividend ETFs offer stability, steady income, and diversification, helping investors amid uncertainty.

Get all your
news in one place.

100’s of premium titles.
One news app.

Meta Stock: The Potential and Pitfalls of Its Reality Labs Bet

Meta Platforms keeps doubling down on its Reality Labs. What is the company's strategy, and what potentially huge benefits could it offer the stock long-term?

If You Could Only Hold 3 Investments for Life, Consider These

Discover 3 must-own investments for lifelong growth. From dividend stocks to a market-beating ETF, these picks offer stability, returns, and long-term wealth.

3 Stocks to Consider With a Possible Recession on the Table

As recession indicators begin to flash, investors may turn to defensive plays for protection—these three stocks offer a compelling case for sturdiness.

AAON Doubles Down: Dividend Raise & Share Buyback Plan

AAON's increased dividend and share repurchase program indicate strong financial health and a commitment to boosting shareholder value.

Get all your
news in one place.

100’s of premium titles.
One news app.

4 Stocks Up 20%+ in the Last Month—Is More Growth Ahead?

While American markets stumble, some stocks are showing outstanding growth. These 4 shares are up 20% or more in the last month.

Insider Scoop: 4 Stocks Insiders Are Buying and Selling

Analyzing recent insider trading trends reveals how key company figures are positioning themselves, potentially signaling future stock movements for investors.

Play Both Sides: 3 Bond ETFs to Balance Offense and Defense

The current volatility in stocks sets up a buying opportunity in bonds; here are three bond ETFs that capitalize on the potential for higher bond prices

Institutional Investors Bet $1B on These 4 Stocks—Should You?

Institutional investors snapped up at least $1 billion in shares of each of these four companies in Q4 of 2024 - should you buy as well?

One Must-Buy Stock and One to Avoid as Tariffs Shake the Market

Recent trade tariffs with Canada have pushed the lumber market into a corner where investors can make or break their portfolios.

These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?

Tech stocks are struggling, pushing major ETFs to bargain-level prices. These four tech ETFs are trading near 50-day lows.

3 Stocks to Buy While Others Stay on the Sidelines

Many top stocks from the last two years aren't the best choices if you're starting a position in 2025; here are three rising stars that may be better options

1 … 11 12 13 14

People

103,467 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

the Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

256,777 stories

The United States

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play